Replies to post #42035 on Therapeutic Solutions International Inc (TSOI)

[doogdilinger]

I wonder how many joe retailers besides those of us already vested here even bothered to read this yellow sticky post from last friday haha!

The day will soon come where/when our hidden biotech gem will be known by the entire world!

And it's not only coming over the very near term horizon...it's going to be a beyond jaw dropping journey fueled by big money not joe retail:)

[twister1]

I think i'm gonna ask for a ....
"New Pair of Dancing Shoes"
For Christmas
Cheers
Have a Great Weekend

[doogdilinger]

Updated TSOI full DD packet as of Monday Nov 22nd, 2021 for anyone just getting started on their due here! TSOI is a fully registered SEC Reporting filer, which means they file fully audited financials and subscribe to OTC Markets Green Shield verified direct from the Transfer Agent Share Structure program:





https://www.otcmarkets.com/stock/TSOI/profile


All of TSOI's PR's, FDA approval PR's & key board member additions YTD:

https://finance.yahoo.com/quote/TSOI/press-releases?p=TSOI



And here's the entire ALL STAR team of career big board established executives already with their name on TSOI's door alongside our scientist CEO folks:

Timothy G. Dixon – President, CEO, & Chairman

Mr. Dixon currently serves as Chief Executive Officer, President, and Chairman of Therapeutic Solutions International, Inc. Mr. Dixon previously served as the President of TMD Courses, Inc. from 2006 to 2012 and; as the President of Splint Decisions Inc. from 2010 to 2011. Mr. Dixon has attended hundreds of hours of continuing medical/dental education throughout the years and has produced many educational DVD’s used by dental professionals worldwide on the subject of parafunctional control, migraine prevention, therapeutic Botox injections, migraine pathophysiology, dental sleep medicine, and other therapeutic protocols. Mr. Dixon also has extensive experience in dealing with corporate compliance matters with the U.S. Food and Drug Administration, (FDA) as well as many international regulatory bodies:
https://therapeuticsolutionsint.com/management/




TSOI CEO Dixon's shareholder education forum:

https://board.therapeuticsolutionsint.com/viewforum.php?f=2&sid=13a8f36abaf3ea8212c019779ed0955c






Thomas Ichim PHD:
https://www.marketscreener.com/business-leaders/Thomas-Ichim-074P9M-E/biography/

FRANCESCO MARINCOLA, MD:
https://www.kitepharma.com/about-us/leadership/kite-leadership-list/francesco-marincola

Santosh Kesari, MD, PHD:
https://www.saintjohnscancer.org/about-us/people/santosh-kesari/

Vijay Mahant MD:
https://www.biospace.com/article/releases/oncology-pharma-appoints-dr-vijay-mahant-as-the-chief-scientific-officer-and-chief-operating-officer/

David P. Hajjar MD:
https://www.brookings.edu/experts/david-p-hajjar/

Boris Minev MD:
https://eutranslationalmedicine.org/boris-minev

Pablo Guzman MD:
https://www.doximity.com/pub/pablo-guzman-md-eb4cae80

Juergen Winkler, MD:
https://www.qfmed.com/

Nassir Azimi, MD:
https://www.sharp.com/san-diego-doctors/dr-nassir-azimi-71718

James Veltmeyer MD:
https://drveltmeyer.com/meet-dr-veltmeyer/

Barry Glassman, DMD:
https://therapeuticsolutionsint.com/CV/Barry_Glassman_CV.pdf

Feng Lin MD PHD:
https://profils-profiles.science.gc.ca/en/profile/dr-feng-lin-phd

Hong Ma, MD, PHD, MBA:
https://biography.omicsonline.org/united-states-of-america/batu-biologics-inc/hong-ma-md-phd-mba-1758889

Howard Leonhardt:
https://leonhardtventures.com/howard-leonhardt/

J. Christopher Mizer:
https://www.vivariscapital.com/executive-team

Dr Boris Reznik:
https://health.usnews.com/doctors/boris-reznik-551130

Peter Farrel PHD:
https://www.webmd.com/peter-c-farrell

Francisco Silva:
Mr. Silva previously served as Chief Executive Officer of two companies engaged in the commercialization of human-based biologics for both research and therapeutic applications. Mr. Silva is the inventor of numerous game-changing technologies in the area of regenerative medicine. His work at PrimeGen was the precursor to the Nobel Prize winning iPSC technology, as well as his subsequent co-discovery of two unique stem cell sources.
https://www.bloomberg.com/profile/person/17243529
https://www.biorestorative.com/




Bio's to all the above TSOI executive mgmt roster and scientific advisory board below:


https://therapeuticsolutionsint.com/management/

https://therapeuticsolutionsint.com/scientific-advisory-board/



TSOI's entire IP pipeline filed to date:

https://therapeuticsolutionsint.com/patent-abstracts/



TSOI Patents and Applications filed by date = 58

The entire Patent & Application list below was put together by centsability who provided the following commentary/insights to his list(I count the ones by this company , and it's subsidiary , and not the JadiCell patent or it would be 59 for ARDS /Lungs , or 60 for CTE / TBI, or 61 for Schizophrenia my friend TradersTrader on ST.
they piled on many JadiCell patents, from the original patent.)

https://board.therapeuticsolutionsint.com/viewtopic.php?t=1094

11-01-2021 Induction of Concurrent Pulmonary Immune Modulation and Regeneration by Protein Mediated Conjugation of Immune Regulatory Cells with Endogenous Progenitor Cells
10-11-2021 Umbilical Cord Derived Regenerative and Immune Modulatory Stem Cell Populations
10-04-2021 Reduction of Neutrophil Extracellular Trap formation by Mesenchymal Stem Cells and their Exosomes
09-22-2021 Stimulation of Mesenchymal Stem Cell Therapeutic Activities by T Regulatory Cells
09-16-2021 Ivermectin Compositions for Treatment of COVID-19
08-23-2021 Umbilical Cord Mesenchymal Stem Cells for Treatment of Chronic Obstructive Pulmonary Disease and Lung Degeneration
08-18-2021 Enhancement of Umbilical Cord Mesenchymal Stem Cell Therapeutic Activity by Stimulators of T Regulatory Cells and/or Cells Expressing CD73
08-11-2021 Induction of Neurogenesis using Umbilical Cord Derived Mesenchymal Stem Cells and Derivatives Thereof
07-06-2021 Treatment of Parkinson’s Disease by Immune Modulation and Regenerative Means
05-24-2021 Immunotherapies for Targeting of Tumor Vasculature
05-21-2021 Lithium as a Monotherapy and/or Stem Cell Adjuvant Therapy for Pulmonary Fibrosis
05-17-2021 Treatment of Major Depressive Disorder by Low Dose Interleukin-2
04-13-2021 Amelioration and Treatment of Opioid Addiction
03-29-2021 Compositions Capable of Stimulating Immunity Towards Tumor Blood Vessels
03-23-2021 Chimeric Cells Comprising Dendritic Cells and Endothelial Cells Resembling Tumor Endothelium
03-16-2021 Pluripotent Stem Cell Derived Dendritic Cells and Engineered Dendritic Cells for Cancer Immunotherapy
03-04-2021 Therapeutic Monocytes for Prevention of Suicidal Ideation
02-22-2021 Ex Vivo Generation of Immunocytes Recognizing Brother of the Regulator of Imprinted Sites (BORIS) Expressing Cancer Stem Cells
02-08-2021 Stimulation of Natural Kill Cell Memory by Administration of Dendritic Cells
01-26-2021 Stimulation of Dendritic Cell Activity by Homotaurine and Analogues Thereof
12-21-2020 Immunotherapy for Opioid Addiction
12-08-2020 Treatment of Major Depressive Disorder and Suicidal Ideations Through Stimulation of Hippocampal Neurogenesis Utilizing Plant-Based Approaches
11-24-2020 Stimulation of NK Cell Activity by QuadraMune Alone and together with Metformin
10-27-2020 Protection/Regeneration of Neurological Function by Endothelial Protection/Rejuvenation using Stem Cells for Treatment of Conditions such as Chronic Traumatic Encephalopathy and Schizophrenia
10-18-2020 Nutraceutical Reduction Prevention and/or Reversion of Multiple Sclerosis
09-24-2020 Personalized Immunotherapies for Reduction of Brain Inflammation and Suicide Prevention
09-14-2020 Immunotherapy of Schizophrenia and Schizophrenia Associated Suicidal Ideation/Suicide
08-28-2020 Upregulation of Therapeutic T Regulatory Cells and Suppression of Suicidal Ideations in Response to Inflammation by Administration of Nutraceutical Compositions Alone or Combined with Minocycline
08-21-2020 Methods of Determining Risk of Suicide and/or Suicidal Ideation by Immunological Assessment
08-05-2020 Prevention of Neuroinflammation associated Memory Loss Using Nutraceutical Compositions
07-28-2020 Neuroprotection and Neuroregeneration by Pterostilbene and Compositions Thereof
07-22-2020 Additive and/or Synergistic Combinations of Metformin with Nutraceuticals for the Prevention, Inhibition and Treatment of SARS-Cov-2 and Associated COVID-19
07-13-2020 Prevention of Pathological Coagulation in COVID-19 and other Inflammatory Conditions
06-30-2020 Augmentation of Natural Killer Cell Activity and Induction of Cytotoxic Immunity Using Leukocyte Lysate Activated Allogeneic Dendritic Cells: StemVacs™
06-22-2020 Treatment of SARS-CoV-2 with Dendritic Cells for Innate and/or Adaptive Immunity
06-15-2020 Nutraceuticals for Suppressing Indolamine 2,3 Deoxygenase
06-11-2020 Nutraceuticals for Reducing Myeloid Suppressor Cells
05-11-2020 Treatment of COVID-19 Lung Injury Using Umbilical Cord Plasma Based Compositions
05-04-2020 Nutraceuticals for the Prevention, Inhibition and Treatment of SARS-Cov-2 and Associated COVID-19
11-04-19 Cellular, Organ, and Whole-Body Rejuvenation Utilizing Cord Blood Plasma and Pterostilbene
09-09-19 Pterostilbene and Formulations Thereof for Protection of Hematopoiesis from Chemotherapy and Radiation
01-21-19 Prevention and Reversion of Chronic Traumatic Encephalopathy through Administration of “Educated” Monocytes and Progenitors Thereof
01-09-19 Autologous Neurogenic Cells and Uses Thereof for Professional Athletes at Risk of Chronic Traumatic Encephalopathy
12-05-18 Treatment of Chronic Traumatic Encephalopathy via RNA Administration
09-25-18 Pterostilbene and Formulations Thereof for Treatment of Pathological Immune Activation
09-17-18 Pterostilbene and Compositions Thereof for Prevention and Treatment of Chronic Traumatic Encephalopathy
08-13-18 Enhancement of Ozone Therapy using Pterostilbene
10-08-17 Synergistic Inhibition of Glioma Using Pterostilbene and Analogues Thereof
03-29-17 Methods of Re-Activating Dormant Memory Cells with Anticancer Activity
03-29-17 Augmentation of Anti-Tumor Immunity by Mifepristone and Analogues Thereof
03-29-17 Activated Leukocyte Extract for Repair of Innate Immunity in Cancer Patients
03-29-17 Stimulation of Immunity to Tumor Stem Cell Specific Proteins by Peptide Immunization
03-29-17 Targeting the Tumor Microenvironment through Nutraceutical Based Immunoadjuvants
04-27-16 Augmentation Of Stem Cell Activity Using Pterostilbene And Compositions Containing Pterostilbene
09-25-15 A Medical Device For Reducing The Risk Of Preterm-Labor And Preterm-Birth
09-15-15 Diagnostic Methods For The Assessment Of Pregnancy Complications
09-02-15 Preventative Methods and Therapeutic or Pharmaceutical Compositions for the Treatment or Prevention of Pregnancy Complications
07-08-15 Augmentation of Oncology Immunotherapies by Pterostilbene Containing Compositions





TSOI Immunotherapies & Product Indication List Updated 10/20/21 from our resident TSOI due diligence expert the poster centsability



https://board.therapeuticsolutionsint.com/viewtopic.php?f=2&t=54


Stage 1 - 4 Cancers (Tumor types) - Breast Cancer , Prostate Cancer w/ StemVacs Immunotherapy Platform https://stemvacs.com/ , BRS-001 https://www.globenewswire.com/news-release/2018/06/11/1519648/0/en/Therapeutic-Solutions-International-Expands-Adoptive-Immunotherapy-Portfolio-by-Incorporation-of-Universal-Cancer-Antigen-into-StemVacs-Dendritic-Cell-Platform.html, NanoStilbeneTM , https://mynanostilbene.com/
Cancer Metabolic DeTox, https://www.globenewswire.com/news-release/2017/05/09/1076506/0/en/Therapeutic-Solutions-files-new-Patent-on-Targeting-the-Tumor-Microenvironment-through-Nutraceutical-Based-Immunoadjuvants.html
and IsoStilbene https://www.globenewswire.com/news-release/2018/06/25/1529010/0/en/Therapeutic-Solutions-International-Releases-IsoStilbene-Injectable-Formulation-of-Pterostilbene-Under-Granted-Patent-for-Augmentation-of-Immunotherapy-and-Targeting-of-Cancer-Stem.html
Liver Cancer, Esophageal Cancer, Melanoma (w/ Ipilimumab) and NanoStilbene (As an adjuvant), https://www.globenewswire.com/news-release/2019/07/22/1885810/0/en/Therapeutic-Solutions-International-Reports-its-NanoStilbene-Nutraceutical-Product-Enhances-Efficacy-of-FDA-Cleared-Cancer-Immunotherapy-in-Animal-Model-of-Cancer.html
Breast Cancer, Prostate Cancer, and Ovarian Cancer w/ Ozone therapy , and NanoStilbene (As an Adjuvant) https://www.globenewswire.com/news-release/2018/08/13/1550904/0/en/Therapeutic-Solutions-International-Reports-Synergistic-Enhancement-of-Ozone-Therapy-Efficacy-in-Prostate-Breast-and-Ovarian-Cancer-Cells-by-Pterostilbene.html
Prostate Cancer w/ NanoPSA https://www.globenewswire.com/news-release/2019/07/08/1879502/0/en/Therapeutic-Solutions-International-Develops-Glucoraphanin-NanoStilbene-Encapsulated-product-for-reduction-of-Prostate-Specific-Antigen-PSA.html
and NanoMyros https://www.globenewswire.com/news-release/2019/07/11/1881456/0/en/Therapeutic-Solutions-International-Develops-Adjuvant-Technology-to-Enhance-Prostate-Cancer-Suppressing-Properties-of-NanoPSA.html
Glioma / Brain Cancers w/ NeuroStilbene , and Brain Cancer Therapeutics https://www.globenewswire.com/news-release/2018/07/16/1537652/0/en/Therapeutic-Solutions-International-Inc-Releases-Intranasal-Formulation-of-Pterostilbene-for-Rapid-Access-to-Blood-Brain-Barrier.html
The Root of Cancer w/ StemVacs "Killer T Cells" (Personalized Adoptive T Cell Therapy)- including T cells capable of killing glioma, leukemia, and mastocytoma https://www.prnewswire.com/news-releases/therapeutic-solutions-international-uses-stemvacs-platform-to-generate-personalized-adoptive-t-cell-therapy-targeting-cancer-stem-cells-301232543.html
Cancer Tumor Blood Vessel Targeting w/ StemVacs (Dendritic Cell based Immunotherapy) https://board.therapeuticsolutionsint.com/viewtopic.php?f=17&t=552
Choking Cancer Blood Vessels w/ TSOI Hybrid Chimeric Cell (fusing StemVacs-V with iPSC derived endothelial cells) https://www.prnewswire.com/news-releases/therapeutic-solutions-international-creates-hybrid-cell-designed-to-educate-immune-system-to-choke-cancer-blood-vessels-301253715.html
Cancer w/ StemVacs - V "Super-Killers" Combining iPSC - (Inducible Pluripotent Stem Cell) Technology with Gene Silencing and NIH Discovered Universal Tumor Antigen https://www.prnewswire.com/news-releases/therapeutic-solutions-international-announces-novel-cancer-resistant-ipsc-derived-dendritic-cell-immunotherapy-stemvacs-v-301248331.html
Cancer w/ StemVacs - V AG (Alpha Gal) https://www.prnewswire.com/news-releases/therapeutic-solutions-international-demonstrates-potent-and-selective-destruction-of-tumor-blood-vessels-by-leveraging-pre-existing-natural-anti-xenogeneic-antibodies-301257387.html
Cancer Tumor Endothelial Targeting w/ StemVacs - V iPSC & Optimized immunological adjuvants https://www.prnewswire.com/news-releases/therapeutic-solutions-international-optimizes-targeting-the-achilles-heel-of-cancer-using-second-generation-tumor-endothelial-targeting-vaccine-stemvacs-v-ipsc-301297580.html
Cancer w/ StemVacs-V iPSC & Other Immunotherapies such as CAR-T therapies, or tumor specific therapeutic vaccines https://www.prnewswire.com/news-releases/therapeutic-solutions-international-reports-amplification-of-cancer-specific-immune-responses-using-second-generation-tumor-endothelial-targeting-vaccine-stemvacs-v-ipsc-301306771.html
Cancer w/ Cyclophosphamide , and NanoStilbene (As an Adjuvant) https://www.globenewswire.com/news-release/2019/07/29/1892915/0/en/NanoStilbene-Nutraceutical-Shown-to-Increase-Ability-of-Cyclophosphamide-Chemotherapy-to-Suppress-Cancer.html
Cancer w/ Ipilimumab (Yervoy® - A checkpoint Inhibitor), and NanoStilbene (As an adjuvant) https://www.globenewswire.com/news-release/2019/07/22/1885810/0/en/Therapeutic-Solutions-International-Reports-its-NanoStilbene-Nutraceutical-Product-Enhances-Efficacy-of-FDA-Cleared-Cancer-Immunotherapy-in-Animal-Model-of-Cancer.html
Cancer w/ Herceptin (A Monoclonal Antibody), and Nanostilbene (As an Adjuvant) https://www.globenewswire.com/news-release/2019/08/26/1906525/0/en/Therapeutic-Solutions-International-Announces-Positive-Clinical-Data-Using-NanoStilbene-to-Stimulate-Immune-System-in-Advanced-Cancer-Patients.html ,
Cancer w/ Rituximab , or Cetuximab , and NanoStilbene (As an adjuvant) https://www.globenewswire.com/news-release/2016/07/11/1076482/0/en/Therapeutic-Solutions-International-Reports-Augmentation-of-Cancer-Immunotherapy-Using-Pterostilbene.html
Melanoma, Glioma, and Lung Cancer w/ StemVacs-V iPSC, and cyclophosphamide https://www.prnewswire.com/news-releases/therapeutic-solutions-international-reports-regression-of-established-tumors-by-combining-its-cancer-blood-vessel-targeting-immunotherapy-with-low-dose-chemotherapy-301276645.html



CTE / Military and Sports Brain Injuries - (Chronic Traumatic Encephalopathy) w/ JadiCell MSCs (Mesenchymal Stem Cells) https://www.globenewswire.com/news-release/2019/07/01/1876699/0/en/Therapeutic-Solutions-International-Obtains-Exclusive-License-for-Patented-Clinical-Stage-Adult-Stem-Cell-for-Treatment-of-Military-and-Sports-Brain-Injuries.html ,
Autologous Neurogenic Stem Cell Banking, https://www.globenewswire.com/news-release/2019/01/09/1682934/0/en/Therapeutic-Solutions-International-Continues-to-Expand-Chronic-Traumatic-Encephalopathy-Intellectual-Property-Portfolio.html
sRNA augmented stem cells, https://www.globenewswire.com/news-release/2018/12/06/1663162/0/en/Therapeutic-Solutions-International-Expands-Chronic-Traumatic-Encephalopathy-Intellectual-Property-Portfolio.html
"Educated" Monocytes / Progenitors, https://www.globenewswire.com/news-release/2019/01/22/1703514/0/en/Therapeutic-Solutions-International-Continues-to-Expand-Chronic-Traumatic-Encephalopathy-Intellectual-Property-Portfolio.html
and NeuroStilbene https://www.globenewswire.com/news-release/2018/10/25/1627211/0/en/Therapeutic-Solutions-International-Announces-CTE-Optimized-NeuroStilbene-Formulation.html
TBI / mTBI / bTBI (blast TBI) - (Traumatic Brain Injury / mild TBI) w/ JadiCell MSCs, https://www.globenewswire.com/news-release/2019/07/01/1876699/0/en/Therapeutic-Solutions-International-Obtains-Exclusive-License-for-Patented-Clinical-Stage-Adult-Stem-Cell-for-Treatment-of-Military-and-Sports-Brain-Injuries.html
and NeuroStilbene https://www.globenewswire.com/news-release/2018/07/16/1537652/0/en/Therapeutic-Solutions-International-Inc-Releases-Intranasal-Formulation-of-Pterostilbene-for-Rapid-Access-to-Blood-Brain-Barrier.html


CRS - (Cytokine Release Syndrome) / Inflammation , Car-T sickness / Immunotherapy side effects w/ NanoStilbeneTM https://www.globenewswire.com/news-release/2018/09/25/1575802/0/en/Therapeutic-Solutions-International-Files-Patent-on-Clinical-Data-Demonstrating-Reduction-of-Inflammatory-Cytokines-Using-NanoStilbene.html


Diabetes, Cardiovascular Disease, and Neurodegenerative Diseases w/ Projuvenol ® https://www.globenewswire.com/news-release/2016/04/28/1076470/0/en/Therapeutic-Solutions-International-Files-Patent-Covering-ProJuvenol-C-and-Its-Active-Ingredient-Pterostilbene.html



Neurological Modulation w/ StemVacs & Homotaurine https://www.prnewswire.com/news-releases/therapeutic-solutions-international-reports-enhancement-of-stemvacs-immune-stimulating-activity-using-neuromodulatory-compound-homotaurine-301215167.html

Neural Inflammation, Regeneration & Protection of Brain Cells w/ NeuroStilbene https://www.prnewswire.com/news-releases/therapeutic-solutions-international-reports-inhibition-of-microglial-activation-with-neurostilbene-300983513.html

Neurodegenerative Conditions / Oxidative Brain and Neural Disorders - MS (Multiple Sclerosis), Stroke / post Stroke recovery, and Alzheimers, w/ Alpha Lipoic Acid https://www.globenewswire.com/news-release/2018/08/06/1547454/0/en/Therapeutic-Solutions-International-Develops-Microemulsion-Formulation-of-Alpha-Lipoic-Acid-for-Intranasal-Delivery.html

Neuroinflammation induced brain damage w/ JadiCell MSCs https://www.prnewswire.com/news-releases/therapeutic-solutions-international-demonstrates-potent-brain-protective-activity-of-jadicells-in-animal-model-of-post-covid-19-neurological-damage-301323081.html

MS (Multiple Sclerosis) w/ NanoStilbene https://www.prnewswire.com/news-releases/therapeutic-solutions-international-reports-positive-preclinical-data-on-multiple-sclerosis--using-nanostilbene-301154733.html



Elevated PSA Levels w/ NanoPSA https://www.globenewswire.com/news-release/2019/07/08/1879502/0/en/Therapeutic-Solutions-International-Develops-Glucoraphanin-NanoStilbene-Encapsulated-product-for-reduction-of-Prostate-Specific-Antigen-PSA.html

and NanoMyros https://www.globenewswire.com/news-release/2019/07/11/1881456/0/en/Therapeutic-Solutions-International-Develops-Adjuvant-Technology-to-Enhance-Prostate-Cancer-Suppressing-Properties-of-NanoPSA.html



RA - (Rheumatoid Arthritis) / Synovitis w/ NanoPSA , https://www.globenewswire.com/news-release/2019/07/08/1879502/0/en/Therapeutic-Solutions-International-Develops-Glucoraphanin-NanoStilbene-Encapsulated-product-for-reduction-of-Prostate-Specific-Antigen-PSA.html

and NanoMyros https://www.globenewswire.com/news-release/2019/07/11/1881456/0/en/Therapeutic-Solutions-International-Develops-Adjuvant-Technology-to-Enhance-Prostate-Cancer-Suppressing-Properties-of-NanoPSA.html




TNF (Tumor Necrosis Factor) / Atherosclerosis / TF (Tissue Factor) Elevations, Sepsis, Cardiovascular Disease, RA , Infection w/ NanoStilbene PKE https://www.globenewswire.com/news-release/2019/02/19/1734360/0/en/Therapeutic-Solutions-International-Continues-to-Refine-NanoStilbene-Formulation.html



Covid 19, SARS, ARDS, Breast Cancer, RA, Depression w/ QuadraMune, https://quadramune.com/ ,https://www.prnewswire.com/news-releases/therapeutic-solutions-international-reports-quadramune-reduces-myeloid-suppressor-cells-in-4t1-mouse-model-of-breast-cancer-301074437.html,

https://www.prnewswire.com/news-releases/therapeutic-solutions-international-announces-positive-preclinical-and-clinical-evaluation-of-nutritional-supplement-quadramune-designed-to-protect-against-covid-19-301070796.html ,

https://www.prnewswire.com/news-releases/therapeutic-solutions-international-division-of-campbell-neurosciences-files-patent-on-quadramune-for-treatment-of-major-depressive-disorder-301189517.html

and NLRP3 Trifecta https://www.youcanordernow.com/NLRP3-Trifecta-_p_33.html



Covid 19 w/ StemVacs 2 https://www.prnewswire.com/news-releases/therapeutic-solutions-international-announces-intention-to-use-clinical-stage-nk-activating-cancer-immunotherapy-for-covid-19-301081006.html

COPD w/ JadiCell MSCs, and various therapeutic combinations https://www.prnewswire.com/news-releases/therapeutic-solutions-international-announces-positive-preclinical-results-using-jadicells-in-animal-model-of-chronic-obstructive-pulmonary-failure-copd-301360477.html

Lung disease / ARDS w/ JadiCell MSCs https://www.prnewswire.com/news-releases/therapeutic-solutions-international-acquires-stem-cell-therapy-that-successfully-completed-fda-double-blind-placebo-controlled-efficacy-study-for-lung-disease-301225932.html

Covid 19 / Delta Variant w/ JadiCell MSCs and IL 2 https://www.prnewswire.com/news-releases/therapeutic-solutions-international-identifies-and-files-patent-on-novel-mechanism-of-action-of-its-fda-phase-iii-cleared-jadicell-treatment-of-covid-19-and-delta-variant-301357756.html

Covid Damaged Lungs w/ Cord blood based immunotherapy https://www.prnewswire.com/news-releases/san-diego-top-doctor-james-veltmeyer-collaborates-with-therapeutic-solutions-international-in-cord-blood-based-immunotherapy-for-covid-19-damaged-lungs-301057622.html

Lung Scarring w/ JadiCell MSCs & lithium carbonate https://www.prnewswire.com/news-releases/therapeutic-solutions-international-develops-novel-stem-cell-based-therapy-to-reduce-lung-scarring-potential-solution-to-post-covid-19-lung-deterioration-301296796.html


COPD / Lung Deterioration w/ QuadraMune & Ivermectin https://www.prnewswire.com/news-releases/therapeutic-solutions-international-identifies-and-files-patent-on-combination-effects-between-its-nutraceutical-quadramune-and-ivermectin-in-animal-models-of-covid-19-pathology-301378661.html


Lung Injury / Lung Rejuvenation w/ JadiCell MSCs & T Regulatory Cells https://www.prnewswire.com/news-releases/therapeutic-solutions-international-discovers-and-files-patent-on-novel-cellular-therapy-combination-for-augmentation-of-lung-repair-in-covid-19-model-301382566.html



Monocyte Immunotherapy for Suicide Prevention & Ideation - Brain inflammation https://www.prnewswire.com/news-releases/therapeutic-solutions-international-spin-off-campbell-neurosciences-announces-umbilical-cord-derived-monocyte-immunotherapy-candidate-for-suicide-prevention-301240517.html

Depression w/ IL-2 Therapy https://www.prnewswire.com/news-releases/therapeutic-solutions-international-and-campbell-neurosciences-announce-preclinical-studies-showing-low-doses-of-fda-cleared-immune-stimulant-interleukin-2-reduces-inflammation-associated-depression-in-animal-model-301292421.html

Schizophrenia w/ Jadicell MSCs, https://www.prnewswire.com/news-releases/therapeutic-solutions-international-files-comprehensive-campbell-platform-patent-for-stem-cell-immunotherapy-of-schizophrenia-301130078.html

and low dose naltrexone and agents stimulating T regulatory cells https://www.prnewswire.com/news-releases/campbell-neurosciences-spin-off-of-therapeutic-solutions-reports-synergistic-reduction-of-schizophrenia-in-animal-models-using-low-dose-naltrexone-and-t-regulatory-cell-stimulation-301313738.html



Opioid addiction w/ Neuroleukin, https://www.biospace.com/article/releases/therapeutic-solutions-international-files-patent-on-neuroleukin-personalized-immunotherapy-for-opioid-addiction/

and NarcoStem https://www.prnewswire.com/news-releases/therapeutic-solutions-international-spin-off-campbell-neurosciences-identifies-mechanism-of-action-for-umbilical-cord-blood-derived-narcostem-drug-rehabilitation-product-301271379.html


Anti - Aging w/ Cord Blood plasma, and NanoStilbene, https://www.prnewswire.com/news-releases/therapeutic-solutions-international-reports-augmentation-of-rejuvenating-activity-of-cord-blood-plasma-by-pterostilbene-300950777.html

and Projuvenol https://www.youcanordernow.com/ProJuvenol-60-Capsule_p_12.html
© 2021 InvestorsHub.com, Inc.
Immune modulation and regeneration w/ Umbilical Cord Derived Regenerative and Immune Modulatory Stem Cell Populations

https://www.prnewswire.com/news-releases/therapeutic-solutions-international-announces-initiation-of-jadicell-manufacturing-program-to-address-upcoming-fda-phase-iii-trial-and-emergency-use-requests-301396937.html

reference list :

(and this is also @ the bottom of the reference list, and is the most recent add to the TSOI Immunotherapies & Product Indication List)

https://board.therapeuticsolutionsint.com/viewtopic.php?t=54&start=30

-Cents